Evidence Hub

Stability Indicating Method Development and Validation for the Simultaneous Estimation of Tadalafil and Dapoxetine Hydrochloride by RP-HPLC in Bulk and Tablet Dosage Form

B. Sasidharan, Sruthi Vinod, S. Manikandan

Zenodo (CERN European Organization for Nuclear Research), 2026

Abstract

Background: A combination of Tadalafil and Dapoxetine hydrochloride is used to manage coexisting erectile dysfunction and premature ejaculation by enhancing erectile response and delaying ejaculation. Objective: For the simultaneous estimation of the drugs Tadalafil along with Dapoxetine hydrochloride in both bulk and tablet dosage forms, a novel stability indication RP HPLC technique has been developed and validated. Method: The technique uses Shim packed 5µm Column18 (4.6×250mm) for separation. Acetonitrile: Water (50:50 v/v), 0.1% TEA, 0.1% OPA (pH 3.5) make up the optimum mobile phase at 1.2 ml/min flow rate, and ultraviolet detection at 264 nm. Results: Dapoxetine hydrochloride and Tadalafil had retention times of 2.1 and 6.2 minutes, respectively. Tadalafil's linearity range was 3–7 µg/ml, whereas Dapoxetine hydrochloride range was 9–21 µg/ml. For both medications, the accuracy ranged from 99.01 to 100.04%. Tadalafil and Dapoxetine hydrochloride had precision of 1.02% and 0.82%, respectively. Tadalafil LOD as well as LOQ are 0.91 µg/ml and 2.76 µg/ml while Dapoxetine hydrochloride are 2.64 µg/mland 8µg/ml. Conclusion:Compared to previously described approaches, the new method is more sensitive, accurate, and precise. Because of the shorter run and retention times, the approach is cost-effective. The resolution for the two analytical substances resulting from forced degradation products (Acid, Base, Hydrogenperoxide, Thermal, and Photolysis) demonstrated the stability…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free